Zanettini R, Antonini A, Gatto G, et al. Valvular heart disease and the use of dopamine agonists for Parkinson’s disease. N Engl J Med 2007;356:39–46.
298.
Roth BL. Drugs and valvular heart disease. N Engl J Med 2007;356:6–9.
299.
Colao A, Galderisi M, Di Sarno A, et al. Increased prevalence of tricuspid regurgitation in patients with prolactinomas chronically treated with cabergoline. J Clin Endocrinol Metab 2008;93:3777– 3784.
300.
Bogazzi F, Manetti L, Raffaelli V, et al. Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: a meta-analysis from clinical studies. J Endocrinol Invest 2008;31:1119–1123.
301.
Krupp P, Monka C. Bromocriptine in pregnancy: safety aspects. Klin Wochenschr 1987;65:823–827.
302.
Jeffcoate WJ, Pound N, Sturrock ND, et al. Long-term follow-up of patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 1996;45:299–303.
303.
Passos VQ, Souza JJ, Musolino NR, et al. Long-term follow-up of prolactinomas: normoprolactinemia after bromocriptine withdrawal. J Clin Endocrinol Metab 2002;87:3578–3582.
304.
Colao A, Di Sarno A, Cappabianca P, et al. Withdrawal of longterm cabergoline therapy for tumoral and nontumoral hyperprolactinemia. N Engl J Med 2003;349:2023–2033.
305.
Biswas M, Smith J, Jadon D, et al. Long-term remission following withdrawal of dopamine agonist therapy in subjects with microprolactinomas. Clin Endocrinol 2005;63:26–31.
306.
Dekkers OM, Lagro J, Burman P, et al. Recurrence of hyperprolactinemia after withdrawal of dopamine agonists: systematic review and meta-analysis. J Clin Endocrinol Metab 2010;95:43–51.
307.
Ono M, Miki N, Amano K, et al. Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro-and macroprolactinomas. J Clin Endocrinol Metab 2010;95:2672– 2679.
308.
Mori H, Mori S, Saitoh Y, et al. Effects of bromocriptine on prolactin-secreting pituitary adenomas. Mechanism of reduction in tumor size evaluated by light and electron microscopic, immunohistochemical, and morphometric analysis. Cancer 1985;56:230–238.
309.
Abram M, Brue T, Morange I, et al. [Pituitary tumor syndrome and hyperprolactinemia in peripheral hypothyroidism]. Ann Endocrinol (Paris) 1992;53:215–223.
310.
Chirito E, Bonda A, Friesen HG. Prolactin in renal failure. Clin Res 1972;20:423.
311.